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Background
Despite extensive clinical concern about rates of obesity in 
patients with schizophrenia, there is little evidence of the 
extent of this problem at a population level. 
Aims
To estimate levels of obesity in a national population sample 
by comparing patients with schizophrenia with matched 
controls.
Method
We calculated levels of obesity for each patient with 
schizophrenia from the national Primary Care Clinical 
Informatics Unit database (n=4658) matched with age, 
gender and neighbourhood controls. 
Results
We demonstrated a significant increased obesity 
hazard for the schizophrenia group using Cox 
regression analysis, with odds ratio (OR) of 1.94 
(95% CI 1.81–2.10) (under the assumption of missing body 
mass index (BMI) indicating non-obesity) and OR=1.68 (95% 
CI 1.55–1.81) where no assumptions were made for missing 
BMI data.
Conclusions
People with schizophrenia are at increased risk of being 
obese compared with controls matched by age, gender and 
practice attended. Priority should be given to research which 
aims to reduce weight and increase activity in those with 
schizophrenia.
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Schizophrenia is a chronic illness associated with significant and 
long-lasting health, social and financial burden for patients, their 
families, other caregivers and the wider society.1 There is a well- 
recognised increase in morbidity and mortality, and life expec-
tancy may be reduced by 20%.2 A significant part of this burden 
relates to comorbid poor physical health.3 The prevalence of obe-
sity in schizophrenia has been cited as 1.5 to 4 times higher than 
the general population.4–6 However, there is little evidence of this 
at a population level. We aimed to provide an estimate of the lev-
els of obesity in a large national population sample by comparing 
cases matched with age, gender and neighbourhood controls.
Method
Design
Descriptive and analytical comparison of target population with 
matched controls.
Data were obtained from the Primary Care Clinical Informatics 
Unit (PCCIU) data-set. Please see http://www.abdn.ac.uk/iahs/
research/primary-care/pcciur/data.php for details of the data col-
lected in this data-set, the methods they have used and the limita-
tions the set may contain.
Since this was the analysis of an anonymised data-set, ethical 
approval to conduct the study was not required.
Inclusions
Adults (aged 16–65 years) registered within any of the 379 prac-
tices contributing to the PCCIU combined database from 2007 to 
2011 with a diagnosis of schizophrenia or with any of the follow-
ing sub-coded diagnoses of schizophrenia: simple, hebephrenic, 
catatonic, paranoid, acute episode, latent, residual or others. In 
Scotland, initial diagnoses of schizophrenia are made by the sec-
ondary care psychiatric team using the ICD-10.7 Four randomly 
selected control patients matched on age (12 months younger or 
older), gender and practice were identified.8
Exclusions
Children (<16 years) at time of schizophrenia diagnosis. In Scottish 
primary care, adulthood is recognised from age 16 years.
Data
For all patients we accessed the latest body mass index (BMI) 
recorded after 2007, including the date recorded, using the stan-
dard PCCIU process for determining BMI. Where no BMI was 
recorded, we requested patients’ heights, weights and the dates 
these were recorded, if recorded within the 3 years before entry 
into the PCCIU database, in order to calculate BMI where possi-
ble. Patients with a recorded BMI were classified as obese (BMI 
≥30 kg/m2) or not obese (BMI  <30 kg/m2). We followed two dif-
ferent methods for dealing with data where no BMI, height and 
weight were recorded in the 3 years before entry into the PCCIU 
database. In the first investigation, these records were classified as 
not obese following the logic that as there was no weight or BMI 
recorded the GP saw no clinical need to obtain these measures. In 
a second investigation, we excluded records where BMI was not 
recorded or calculable. For descriptive purposes and to ensure a 
matched sample, we identified the age, gender and practice code 
for all cases and controls.
Analysis
Descriptive statistics were reported as means and standard devi-
ations or counts and percentages as appropriate. Rates of obesity 
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were compared between cases and controls using χ2 test. We used a 
Cox proportional hazards regression model to estimate the odds of 
obesity among cases versus controls for all and across three broad 
age categories at the time of BMI recording (16–29, 30–49 and 
50–65 years). Data were analysed using SPSS Version 24.
Results
The PCCIU database yielded 4941 cases and 19 752 controls 
matched by age, gender and practice. Cases of schizophrenia, where 
BMI was only recorded or could be calculated prior to diagnosis, 
were excluded (n=281). Following clinical guidance, cases and con-
trols were excluded where the recorded BMI was ≤14 or ≥60 as this 
was deemed to be an unreliable recording (n=16). Finally, cases and 
controls were excluded if aged <16 years on the date of BMI. This left 
a total sample of 24 344 (4658 cases, 19 686 controls). Mean age of 
cases was 44.7 years (s.d.=10.83) and for controls it was 43.23 years 
(s.d.=11.63). A total of 3109 cases (66.7%) were male and 13 154 
controls were male (66.8%). A total of 1472 cases (31.6%) were cate-
gorised as obese compared with 3843 (19.5%) controls (χ2 P<0.001) 
(where missing BMI data were treated as ‘not obese’). Under this 
assumption, there was an increased obesity hazard if diagnosis of 
schizophrenia was present, odds ratio (OR)=1.94 (95% CI=1.81–
2.10). Under the assumption where missing BMI data were treated 
as ‘missing’, obese cases remain as 1472 (but as 36%) compared with 
3843 (25.4%) controls (χ2 P<0.001). Under this assumption, there 
was an increased obesity hazard if diagnosis of schizophrenia was 
present, OR=1.68 (95% CI=1.55–1.81). We were unable to conduct 
analysis within age categories under the first assumption that miss-
ing BMIs were treated as ‘not obese’. This was due to BMI and ‘age at 
BMI’ having similar missing data with extensive overlap. However, 
analysis was possible under the second assumption where missing 
BMI data were treated as missing. Table 1 presents odds of obesity 
within age categories for these analyses.
Discussion
Using a large database representative of the Scottish population, 
we found that people with a diagnosis of schizophrenia have an 
increased hazard of being obese when compared with adults 
matched by age, gender and practice attended. Our analyses 
show that even within a nation with a substantial obesity preva-
lence, patients with schizophrenia are significantly more likely to 
be obese. Furthermore, the difference in rates of obesity is greater 
between the schizophrenia and control groups across all three age 
categories with the differences being greater with younger age.
Our data are drawn from the PCCIU database which draws 
data from 379 participating practices and approximately 1 million 
patients. Thus, these results provide strong evidence of the national 
scale of the obesity problem for patients with schizophrenia which, 
when coupled with findings that people with schizophrenia are 
significantly more sedentary than the general population,9 highlight 
the necessity for future research and funding into interventions to 
address the problem. The importance of this has also been identi-
fied by a Cochrane review of interventions to address weight gain 
in patients with schizophrenia10 and a recent editorial discussing the 
need for evidence-based interventions that increase physical activity 
in order to improve health and reduce premature mortality in people 
with schizophrenia.11 Our data suggest that such interventions would 
be worth targeting patients with schizophrenia in early adulthood.
Although we endeavoured to conduct as comprehensive an 
examination of the available data as was possible, there are still 
several limitations which may have affected our results. We could 
not control for potentially inaccurate recordings within the PCCIU 
data-set, save exclude suspect cases; however, we did make some 
assumptions regarding which data to examine. In the first assump-
tion, we considered that the lack of a recorded BMI for a study 
control indicates the likelihood of them not being obese. We con-
sidered this to be the most logical approach to consider the miss-
ing data to be a likely indication that general practitioners did not 
take such measurements as they had not perceived a risk of obesity. 
However, we could not be certain of this. So we included a fur-
ther analysis where we excluded controls without a registered BMI. 
Under such an assumption, we sought to avoid an underestimate 
of the risk, particularly given the obesity levels across Scotland as 
a whole. A further potential limitation to our findings may result 
from the assumption that obtaining controls from the same general 
practice catchment areas as cases would result in representative-
ness in terms of other important factors such as deprivation sta-
tus. Practice controls can only be considered representative of the 
general distribution of the practice population involved which as a 
group may well be diverse.12
In spite of the enormous potential personal and health costs 
involved, there is to date an insufficient evidence base to guide 
clinicians towards the adoption of effective interventions to 
address obesity for their patients’ benefit. Given the very high 
levels of both obesity and sedentary behaviour among people 
with schizophrenia, priority should be given to research which 
aims to reduce weight and increase physical activity in this group. 
Improving physical activity alone, however, is unlikely to reduce 
the prevalence of metabolic syndrome since aetiological factors 
are much more complex.
Table 1 Obesity in patients with schizophrenia versus controls by age categories (analysis under parsimonious assumption where missing body 
mass index (BMI) is treated as missing)
Age, years
Obese with schizophrenia diagnosis
N (%)
Obese controlsa
N (%)
Cox regression hazard
OR (95% CI) χ2 P
16–29 134 (31.4) 279 (11.9) 2.98 (2.20–4.04) <0.001
30–49 813 (35.9) 1951 (24.6) 1.72 (1.54–1.93) <0.001
50–65 525 (37.6) 1613 (33.3) 1.23 (1.08–1.40) 0.002
a. Where missing BMI data were treated as ‘not obese’.
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